Intravenous tissue plasminogen activator in acute branch atheromatous disease: Does it prevent early neurological deterioration?
- 1 November 2016
- journal article
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 33, 194-197
Abstract
No abstract availableKeywords
Funding Information
- Pusan National University Yangsan Hosptial
This publication has 29 references indexed in Scilit:
- Aggressive Antiplatelet Treatment for Acute Branch Atheromatous Disease Type Infarcts: A 12-year Prospective StudyInternational Journal of Stroke, 2014
- Treatment Outcomes of Tissue Plasminogen Activator Infusion for Branch Atheromatous DiseaseJournal of Stroke and Cerebrovascular Diseases, 2013
- Clinical Evaluation of Lacunar Infarction and Branch Atheromatous DiseaseJournal of Stroke and Cerebrovascular Diseases, 2013
- Guidelines for the Early Management of Patients With Acute Ischemic StrokeStroke, 2013
- Characteristics of intracranial branch atheromatous disease and its association with progressive motor deficitsJournal of the Neurological Sciences, 2011
- Ischemic stroke related to intracranial branch atheromatous disease and comparison with large and small artery diseasesJournal of the Neurological Sciences, 2011
- Branch atheromatous disease: How do we analyze its pathophysiology and treat to prevent the progression of neurological symptoms for good prognosis?Rinsho Shinkeigaku, 2010
- Predictors of Early Arterial Reocclusion After Tissue Plasminogen Activator-Induced Recanalization in Acute Ischemic StrokeStroke, 2005
- Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activatorNeurology, 2002
- Intracranial branch atheromatous diseaseNeurology, 1989